Back to Journals » Infection and Drug Resistance » Volume 18
The Impact of Endogenous Hydrogen Sulfide on Bacterial Resistance
Authors Liu J
, Qi Y, Xiao X, Zhang Y
Received 28 June 2025
Accepted for publication 27 October 2025
Published 15 November 2025 Volume 2025:18 Pages 5995—6005
DOI https://doi.org/10.2147/IDR.S550265
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Hazrat Bilal
Jiaqi Liu,1,* Yize Qi,1,* Xiaoguang Xiao,2 Yongli Zhang1
1Department of Critical Care Medicine, First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, People’s Republic of China; 2Department of Clinical Laboratory, First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Yongli Zhang, Email [email protected] Xiaoguang Xiao, Email [email protected]
Abstract: Infectious diseases, especially sepsis from bacterial infections, significantly threaten global health, with antimicrobial resistance (AMR) complicating treatment and increasing clinical burdens. Antibiotic overuse contributes to AMR by creating selective pressure, reducing the efficacy of traditional therapies, and necessitating new approaches. Endogenous hydrogen sulfide (H2S), a gaseous signaling molecule produced by most bacteria through cystathionine-γ-lyase (CSE), cystathionine-β-synthase (CBS), and 3-mercaptopyruvate sulfurtransferase (3MST), plays a crucial role in bacterial resistance. This review explores the biological functions of bacterial endogenous H2S and its impact on AMR. H2S enhances resistance by neutralizing antibiotic-induced reactive oxygen species (ROS), reducing oxidative stress and DNA damage, and promoting biofilm formation, which obstructs antibiotic penetration and facilitates resistance gene exchange. Furthermore, enhancing H2S-based assays could significantly improve the diagnosis of AMR. Additionally, strategies such as targeting H2S metabolism—through the use of H2S synthase inhibitors or disrupting biofilms via H2S clearance—or the combination of H2S synthase inhibitors with antibiotics, may reverse resistance. A deeper understanding of the mechanisms by which H2S mediates resistance is essential for the development of advanced diagnostic tools and innovative therapies to combat AMR. Its clinical translation may reverse AMR passivity, guide antibiotic sensitizer development, and optimize therapies, holding significant clinical and translational value.
Keywords: endogenous hydrogen sulfide, antibiotic resistance, infectious diseases
Introduction
Infectious diseases represent significant threats to human health, with sepsis being a clinical syndrome characterized by a dysregulated host response to infection, leading to organ dysfunction.1 Infectious diseases pose substantial threats to human health, with sepsis identified as a clinical syndrome marked by an aberrant host response to infection, resulting in organ dysfunction. As a predominant condition within critical care medicine, sepsis exerts a considerable clinical burden. Globally, it accounts for over 48.9 million new cases and in excess of 11 million deaths each year, with a mortality rate of 19.7%, thereby imposing significant challenges on patients, healthcare systems, and society at large.2 Bacterial infections constitute a primary precipitant of sepsis, wherein toxins released by pathogens, coupled with the host’s exaggerated immune response, may culminate in organ failure. Clinical management strategies focus on the eradication of the infection source, judicious administration of antimicrobial agents, the application of immunoadjuvant therapies, and the rectification of pathophysiological disturbances.3 Antibiotic therapy remains a cornerstone in the management of sepsis; however, the inappropriate use of antibiotics has contributed to the escalating issue of antibiotic resistance.4,5 This resistance has emerged as a critical global public health challenge, primarily driven by selective pressure exerted through antibiotic use.6 The escalating issue of antimicrobial resistance (AMR) has significantly diminished the effectiveness of conventional antibiotics, thereby heightening the risk of treatment failure and underscoring the critical necessity for the development of novel therapeutic strategies.7 To address the clinical challenge of antibiotic resistance, strategies beyond the development of novel antibacterial agents are required. One promising approach involves targeting bacterial metabolic pathways, specifically the endogenous hydrogen sulfide (H2S) metabolic pathway, which may offer a novel therapeutic avenue to combat antibiotic resistance.8
H2S is a colorless gas characterized by a distinctive rotten-egg odor.9 It is classified into exogenous and endogenous forms based on its biosynthetic origin. Exogenous H2S is derived from external environmental sources or experimental interventions, primarily originating from: biogenic processes in anaerobic ecosystems, industrial chemical byproducts, and the decomposition of sulfur-containing organic matter during waste management in livestock and poultry farming.10 In contrast, endogenous H2S is synthesized through an organism’s own metabolic processes and exhibits biological activity.11 As a gaseous signal molecule, endogenous H2S plays essential regulatory roles across various physiological systems, including the cardiovascular, nervous, digestive, endocrine, reproductive, and immune systems.12–18 Disruptions in H2S metabolism can lead to a range of pathological conditions, such as atherosclerosis, hypertension, diabetes, and neurodegenerative diseases. Despite substantial advancements have been achieved in researching the biological roles of H2S in mammalian systems,19 there is little research on the effect of H2S on bacteria and its underlying mechanism, studies have shown that the majority of bacterial strains are capable of producing endogenous H2S. H2S is predominantly synthesized within the body through enzymatic catalysis involving cystathionine-γ-lyase (CSE), cystathionine-β-synthase (CBS), and 3-mercaptopyruvate sulfurtransferase (3MST). This molecule exhibits intricate immunomodulatory and cytoprotective properties. In bacterial systems, H2S is capable of activating antioxidant mechanisms, neutralizing reactive oxygen species (ROS) generated by antibiotic exposure, mitigating oxidative stress-induced damage, and preventing bacterial cell death resulting from such oxidative insults. Furthermore, H2S facilitates the development of bacterial biofilms. These biofilms not only impede the physical penetration of antibiotics but also create a microenvironment conducive to the exchange of antibiotic resistance genes among bacteria. This process further augments the resistance of bacterial populations, thereby facilitating their survival and reproduction under antibiotic pressure.20 H2S serves as a multifunctional defense factor that is widely present in bacteria and is intricately linked to bacterial growth, bacterial antibiotic resistance, and virulence.
Biosynthetic Pathway of Endogenous H2S in Bacteria
Specific enzyme systems (eg, cysteine desulfhydrases, sulfate reductases, etc.) are present in the bacterial cytoplasm. These enzyme systems can catalyze the sulfur-containing substrates (eg, sulfur-containing amino acids, sulfates) taken up by bacteria from the environment, facilitating metabolic reactions within the bacteria that ultimately produce H2S. H2S is released outside the bacteria through transmembrane diffusion. Endogenous H2S in bacteria is synthesized through multiple pathways, which may function in a complementary manner. In certain bacterial species, H2S production occurs via the metabolism of sulfur-containing amino acids. For instance, Escherichia coli (E. coli) generates H2S through the catabolism of L-cysteine, facilitated by the enzyme cysteine desulfurase.21 In 2011, Konstantin Shatalin’s genomic analysis demonstrated that the majority of bacterial species possess homologues of mammalian CBS, CSE, or 3MST.20 Notably, Bacillus anthracisI(B. anthracis), Pseudomonas aeruginosa (P. aeruginosa) and Staphylococcus aureus (S. aureus) contain homologues for CBS/CSE, yet they do not have homologues 3MST. Following the sequential inactivation of CSE and CBS using transposon insertion technology, the experimental results indicated that CSE serves as a crucial enzyme in the biosynthesis of bacterial endogenous H2S, whereas CBS contributes a relatively minor role in this process.20 Both CBS and CSE enzymes predominantly utilize cystathionine as a substrate, with pyridoxal phosphate and hemoglobin serving as cofactors. CBS synthesizes cystathionine from condensed cysteine and serine, while CSE catalyzes the conversion of cystathionine to L-cysteine, which is subsequently catalyzed by CSE/CBS to produce H2S. CSE exhibits broad substrate specificity and facilitates H2S production through various pathways. For instance, it catalyzes the conversion of cystathionine to L-cysteine, ammonia, and α-ketobutyric acid;22 and it also mediates the decomposition of L-cysteine into pyruvate, ammonia, and thiocysteine, the latter of which further generates H2S.23 E. coli possesses orthologs for 3MST but lacks orthologs for CBS and CSE. The 3MST protein contains a rhodanese-like domain and exists in monomeric and dimeric forms. It is catalytically active in its monomeric state and becomes inactive upon transitioning to a dimeric structure at the conclusion of the reaction. Cysteine aminotransferase facilitates the conversion of cysteine and keto acids into 3-mercaptopyruvate, which is subsequently desulfurated by 3MST to generate H2S.24
The gastrointestinal tract is the principal site for H2S production, predominantly facilitated by the catabolism of cysteine by gut microbiota, including genera such as Clostridium, Salmonella, Klebsiella, and Streptococcus within the intestinal lumen. A smaller fraction of H2S is synthesized by sulfate-reducing bacteria (SRB). The gut environment is characterized by anaerobic conditions, which are conducive to the proliferation of SRB. These bacteria utilize organic or inorganic compounds as electron donors in their metabolic processes, reducing sulfate, which serves as an electron acceptor, to generate H2S. The primary SRB involved in this process are species from the Desulfovibrio and Vibrio genera, which are capable of degrading and reducing sulfur-containing compounds such as sulfate, sulfite, and thiosulfate to produce H2S.25,26
In natural environments, bacteria predominantly produce H2S via two principal pathways. The first involves the reduction of inorganic sulfides; for example, in anaerobic settings such as the deep sea, sulfate-reducing bacteria synthesize H2S by reducing sulfates, sulfites, and thiosulfates. The second pathway entails the decomposition of organic matter. Patricia Q. Tran et al conducted a screening of bacteria prevalent in natural lakes, identifying Pseudomonas maltophilia, Bacillus bentonii, and Bacillus bifidus as capable of degrading cysteine to produce H2S under aerobic conditions.27
Importantly, the pathway for H2S synthesis exhibits variability among different bacterial species, reflecting their specific species characteristics, environmental conditions, and metabolic needs.
Physiological Functions and Antibiotic Resistance of Endogenous H2S in Bacteria
Antioxidant Stress Effect
Antioxidant and Free Radical Scavenging Activity of Endogenous H2S
The Fenton reaction involves the generation of hydroxyl radicals (·OH) through the interaction of hydrogen peroxide (H2O2) with ferrous iron (Fe2+). ·OH are produced when hydroxide ions lose an electron, resulting in highly oxidative species that can damage DNA, proteins, and lipids.28 It has been observed that antibiotics can stimulate the production of ·OH in bacteria via the Fenton reaction. Shatalin demonstrated that bacteria can generate endogenous H2S to mitigate oxidative stress, thereby enhancing resistance to antibiotics. The wild-type E. coli degraded H2O2 at a rate 1.5 times that of the 3MST-deficient strain, while the overexpressing strain exhibited an even higher degradation rate.20,29 In a study, E. coli was treated with quinolone, β-lactam, and aminoglycoside antibiotics, all of which prompted the production of ·OH in the bacteria. The introduction of 2,2′-bipyridyl, an iron ion chelator, effectively inhibited the Fenton reaction, thereby reducing the production of ·OH and subsequently increasing bacterial survival. Furthermore, the treatment of E. coli with thiourea, a potent ·OH scavenger, effectively quenched the ·OH generated by the Fenton reaction, thereby enhancing bacterial survival. The addition of 2,2′-bipyridine or thiourea resulted in a bacterial survival rate that was three times higher than that of the control group. This observation underscores the role of ·OH in the bactericidal action of antibiotics. Additionally, it has been demonstrated that the introduction of H2S donors markedly diminishes the bactericidal efficacy of antibiotics against E. coli. H2S proved to be as effective as 2,2′-bipyridyl or thiourea in shielding E. coli from oxidative stress induced by gentamicin, thereby confirming that H2S can scavenge ·OH and protect bacteria from oxidative damage (Figure 1).30
Effects of Endogenous H2S on Bacterial Iron Metabolism
Antibiotics generate ·OH mainly through the reaction of Fe2+ with H2O2 in bacteria, and H2S can directly scavenge ·OH, but also by regulating bacterial iron metabolism, which in turn reduces ·OH production. Iron-sulfur clusters (ISCs) are highly conserved protein cofactors consisting of proteins, iron, and sulfur, and knockdown of the ISCs gene significantly reduces the iron content in bacteria, and iron release from iron-sulfur clusters mainly relies on superoxide catalytic.31 The introduction of antibiotics facilitates the conversion of NADH to NAD+, resulting in the production of substantial quantities of superoxide, which subsequently exerts bactericidal effects.32
Ferric uptake regulator (fur) is the most important transcriptional regulator of iron metabolism in bacteria, using Fe2+ as a co-deterrent to inhibit the synthesis of iron carriers and repress the expression of iron uptake genes to maintain the dynamic balance of Fe2+ in bacteria.33 Fur regulates the level of free iron, which in turn determines the antioxidant efficiency of H2S. ΔFur (fur-deficient strain) leads to a surge in intracellular free iron and exacerbates oxidative damage. Exposure to H2O2 resulted in a 40-fold higher death rate in the Δfur E. coli mutant compared to the wild-type strain. In Δfur strains, the inhibitory effect of fur on iron uptake genes is abolished, resulting in a significant increase in intracellular free Fe2+ concentration. A large amount of Fe2+ participates in the Fenton reaction, generating more ·OH and drastically raising the risk of DNA damage and cell death. For Δfur strains, H2S produced by 3MST can directly chelate excessive free Fe2+ and block the Fenton reaction, thereby restoring the cell’s resistance to H2O2. This confirms that H2S exerts a protective effect by chelating free iron. The reaction of L-cysteine with Fe3+ generates L-cysteine with Fe2+, which in turn promotes the Fenton reaction. E. coli counteracts oxidative stress by chelating free iron using L-cysteine and H2S.20,30
RyhB iron-responsive small regulatory non-coding RNA, first identified in E. coli induced by a low iron environment.34,35 RyhB can post-transcriptionally regulate the target of encoded proteins in response to bacterial iron-starvation mRNA for iron storage and use; ryhB promotes iron carrier synthesis and uptake. In transcriptomics studies in E. coli, ryhB has been shown to directly or indirectly affect the transcription of many genes that are closely linked to Fe-S metabolism and ferritin maturation. RyhB is repressed by fur, and Δfur leads to constitutive iron import and hypersensitivity to oxidative DNA damage. Addition of Fecl3 to E. coli resulted in a decrease in H2S, suggesting that H2S can directly chelate Fe3+. Addition of H2O2 to non-H2S-producing (mstA knockout) and Δfur E. coli resulted in lower survival, while E. coli overexpressing mstA and Δfur were almost completely immune to the killing effect of H2O2, as mstA expression is proportional to the H2S-producing level, suggesting that endogenous H2S can directly chelate iron to eliminate H2O2-mediated toxicity and iron overloading damage to bacteria.30 RyhB indirectly affects the demand for H2S by regulating iron metabolism. In ΔryhB strains, the intracellular free iron level is slightly higher than that in wild-type strains, and the demand for H2S to chelate free iron increases accordingly. There is no significant difference in H2O2 sensitivity between the Δfur ΔryhB double mutant and the Δfur strain; however, overexpression of mstA restores the sensitivity of both strains. This confirms that the effect of ryhB on oxidative sensitivity is ultimately regulated by the chelation of free iron by H2S. H2S does not directly regulate the expression of ryhB. QRT-PCR detection showed that deletion or overexpression of mstA had no significant effect on the transcriptional level of ryhB, which further confirms that there is no direct regulatory relationship between the two. Instead, they are indirectly linked through the common “fur-iron” pathway.30
Fur and ryhB play an important role in regulating adaptive responses during bacterial infection, making them important targets against bacteria. Fur acts as an upstream regulator: it regulates the expression of iron uptake genes such as ryhB by binding to Fe2+, thereby maintaining intracellular free iron levels. RyhB functions as a midstream executor: when fur is inactivated, it modulates intracellular iron distribution by degrading the mRNA of iron-consuming genes. H2S serves as a downstream protector: by chelating the free iron regulated by the fur/ryhB pathway, it blocks the Fenton reaction and defends against oxidative damage. By sequencing E. coli RNA, H2S was found to upregulate iron uptake genes and increase iron storage via YgaV, which is critical for E. coli resistance to oxidative stress and resistance to antibiotics.6 H2S levels in Vibrio cholerae are positively correlated with iron uptake, which in turn increases iron stores to increase catalase activity and enhance anti-oxidative stress.36 However, no study has yet demonstrated a direct relationship between H2S and iron. For example, how H2S chelates intra-bacterial iron and whether it blocks intra-bacterial metal active sites to reduce antibiotic damage to bacteria.
Cysteine and Endogenous H2S
Cysteine, a sulfur-containing amino acid, serves as a crucial substrate for H2S production. CysB, a member of the LysR family of prokaryotic transcriptional regulatory proteins, plays a significant role in regulating sulfur metabolism across diverse bacterial species. It enhances the expression of genes involved in sulfate metabolism and cysteine synthesis while also monitoring endogenous L-cysteine levels.37,38 Elevated concentrations of L-cysteine can be toxic to bacteria and facilitate the Fenton reaction. Reduced cysteine levels have been shown to increase antibiotic resistance in E. coli by modulating intracellular ROS levels. This modulation occurs through the influence of endogenous cysteine on the Fenton reaction, thereby impacting bacterial resistance.
Endogenous H2S Enables Enzymes Activity
Antioxidant enzymes (such as superoxide dismutase (SOD), catalase, and glutathione peroxidase) can scavenge ROS induced by antibiotics, alleviate oxidative damage, and protect bacteria from oxidative stress mediated by antibiotics—thereby maintaining the integrity of bacterial physiological functions. This process indirectly enhances the survival ability of bacteria under antibiotic pressure, ultimately manifesting as increased bacterial resistance.39 Endogenous H2S has the capability to scavenge ·OH by augmenting the activities of catalase and SOD. Research indicates that H2S can directly inhibit heme-containing catalase and enhance the bactericidal effect of H2O2. However, this inhibition is both transient and immediate. In contrast, H2S functions as a long-term signaling molecule, promoting the expression of systems involved in the scavenging and repair of H2O2, thereby protecting bacteria from oxidative stress.40 In wild-type E. coli stimulated by H2O2, the expression of SOD is more than 1.5 times greater compared to 3MST type E. coli.
The overexpression of 3MST in E. coli results in elevated SOD activity, with a direct proportionality observed between SOD activity and 3MST expression, thereby demonstrating that endogenous H2S can enhance antioxidant enzyme activity.20 In Vibrio cholerae, H2S production is primarily catalyzed by CBS-mediated conversion of L-cysteine. This process reduces free iron through the activation of iron uptake and storage mechanisms and enhances peroxidase activity at the post-translational level, thereby augmenting the organism’s resistance to oxidative stress.36 Antioxidant enzymes can help bacteria resist the bactericidal mechanism of antibiotics through multi-level synergistic effects, including scavenging ROS, maintaining redox balance, and promoting damage repair, ultimately serving as a crucial system that supports bacterial antibiotic resistance.
Anti-DNA Damage Effects of Endogenous H2S
Antibiotics facilitate the Fenton reaction, resulting in the formation of peroxides that induce double-stranded DNA breaks in bacteria. This DNA damage activates the SOS response, a repair mechanism triggered by bacterial DNA damage. The SOS response primarily involves homologous recombination, nucleotide excision repair, and transdamage synthesis. Initially, it was believed that the SOS response was primarily activated by abnormal single-stranded DNA; however, subsequent research has demonstrated that double-stranded DNA breaks also elicit this response (Figure 1).41
Among the mechanisms involved, recA expression plays a pivotal role in the repair of DNA double-strand breaks, primarily through the process of homologous recombination repair, which is facilitated by catalytic strand exchange and invasion of homologous double-stranded DNA.42 The introduction of antibiotics or H2O2 induces DNA double-strand breaks in bacteria. In contrast, the overexpression of 3MST or the administration of H2S donors has been shown to inhibit DNA breaks in E. coli.20
Effect of Endogenous H2S on Bacterial Growth
Persisters constitute subpopulations of dormant bacteria that endure exposure to lethal concentrations of antibiotics.43 These cells exhibit slow growth or stagnation and demonstrate a transient yet high level of antibiotic resistance. Upon the removal of antibiotic stress, persisters revert to their normal bacterial phenotype, resuming growth and proliferation. They play a crucial role in the persistence of bacterial infections and significantly contribute to the development and regeneration of antibiotic-resistant bacteria during infection treatment.44
In 2021, Shatalin and his research team found that the sole condition of CSE deletion is sufficient to render S. aureus and P. aeruginosa sensitive to low doses of antibiotics from different classes, including gentamicin (an aminoglycoside), norfloxacin (a quinolone), and ampicillin (a β-lactam). The survival rate of CSE-deficient S. aureus and P. aeruginosa was significantly diminished following antibiotic treatment compared to wild-type strains.45 P. aeruginosa exhibited a notably lower survival rate of persister cells post-antibiotic administration relative to wild-type strains, indicating that endogenous H2S promotes the formation of persister bacterial populations. The surviving persister cells produce more H2S than typical colonies, and elevated H2S levels inhibit the tricarboxylic acid cycle, thereby reducing bacterial metabolism and enhancing antibiotic efficacy. Persistent bacteria are not antibiotic-resistant bacteria themselves, but their “phenotypic tolerance” trait serves as a key catalyst for the emergence of antibiotic-resistant bacteria. By providing a survival window for antibiotic-resistant mutant strains and surviving synergistically with antibiotic-resistant bacteria, persistent bacteria indirectly promote the development and spread of antibiotic resistance.
Effect of Endogenous H2S on Bacterial Biofilm Formation
Biofilms constitute complex communities of microorganisms that adhere to either biotic or abiotic surfaces, exhibiting significantly enhanced resistance to antibiotics relative to their planktonic counterparts.46 Notably, Gram-negative bacteria demonstrate a pronounced propensity for biofilm formation. For instance, P. aeruginosa is known to colonize both the human body and medical devices by forming a biofilm characterized by an asymmetric bilayer composed of phospholipids and lipopolysaccharides. This bilayer functions as a selective barrier, effectively impeding the penetration of antibiotics. The bacterial membrane is characterized by the presence of β-barrel protein channels, with OprF serving as the predominant pore protein that facilitates the non-specific uptake of ions and sugars, thereby impeding antibiotic penetration. Additionally, the membrane contains other specialized pore proteins, including OprD, which is specific for basic amino acids, OprB, which is specific for carbohydrates, and OprP, which is specific for phosphates. The formation of biofilms further complicates antibiotic treatment, resulting in infections that are challenging to manage and may lead to recurrent episodes.47
H2S is integral to biofilm formation, as it facilitates the synthesis and stabilization of the biofilm matrix, thereby enhancing bacterial viability. In P. aeruginosa, the CSE leads to a reduction in biofilm formation, with a concomitant down-regulation of biofilm-associated genes, particularly those involved in the biosynthesis of alginate and other exopolysaccharides, as revealed by transcriptomic analyses.45 Moreover, endogenous H2S exerts a positive influence on the establishment of microbiota biofilms. In rodent models of colitis, the administration of H2S donors has been shown to mitigate inflammation and restore microbiota biofilms.48
Effect of Endogenous H2S on Antibiotic
CBS, CSE, and 3MST are critical enzymes involved in the biosynthesis of H2S in bacteria. Inhibition of these enzymes has been shown to increase bacterial susceptibility to antibiotics in species such as B. anthracis, S. aureus, P. aeruginosa, and E. coli. Notably, E. coli deficient in 3MST, as well as P. aeruginosa and S. aureus deficient in CBS/CSE, did not exhibit significant growth defects. However, these H2S enzyme-deficient strains demonstrated heightened antibiotic sensitivity compared to their wild-type counterparts. Furthermore, the introduction of H2S donors mitigated the bactericidal effects of antibiotics on the enzyme-deficient strains, indicating that endogenous H2S plays a role in enhancing antibiotic resistance to antibiotics.20
Additionally, studies on Mycobacterium tuberculosis have reported enhanced hypoxic survival in recombinant bacteria through increased H2S production. In this context, AlaE, a cysteine efflux pump, has demonstrated significant cytoprotective effects.49
Methods for the Detection of H2S in Bacteria
The detection of specific enzymes or metabolites in bacteria represents a viable approach for evaluating antibiotic resistance. Within the antibiotic metabolic pathways of bacteria, H2S emerges as a notable antibiotic metabolite resulting from biodegradation. Consequently, methodologies for detecting H2S-associated antibiotic-resistant bacteria are continually advancing. Additionally, novel detection methodologies, such as the fluorescent probe technique, employ fluorescent probes with specific affinities for H2S or antibiotic-resistant bacteria, allowing for the rapid and sensitive detection of H2S-associated antibiotic-resistant bacteria. This approach yields results in a relatively short timeframe and permits in situ detection, thereby offering a more convenient method for clinical diagnosis. H2S, an emerging metabolic marker for β-lactam antibiotics, can be utilized for the screening of antibiotic resistance.50
Nanoprobes that selectively monitor fluctuations in H2S concentrations for the imaging and screening of H2S-associated antibiotic resistance represent a promising diagnostic approach for differentiating between β-lactam antibiotic-resistant S. aureus and non-resistant strains. This technique also facilitates the exploration of novel diagnostic strategies aimed at identifying H2S-associated resistance pathways.51 Furthermore, advancements in biosensor technology are increasingly being utilized for the detection of these bacteria. By integrating biometric elements with signal transduction components, these biosensors enable real-time and rapid detection of bacteria and their associated markers.
Detection of Antibiotic-Resistant Bacteria Associated with H2S
Detection of specific enzymes or metabolites in bacteria can be one of the methods to assess antibiotic resistance, and H2S is one of the antibiotic metabolites produced by biodegradation in the antibiotic metabolism pathway of bacteria, and the detection methods of antibiotic-resistant bacteria associated with H2S are constantly evolving. The traditional culture method determines antibiotic resistance by culturing the bacteria on a specific medium, observing their growth and H2S production characteristics, and combining it with antibiotic susceptibility testing, but the method is time-consuming and usually takes 2–3 days. Molecular biology-based detection methods, such as PCR technology, can rapidly detect genes related to H2S production and antibiotic resistance in bacteria with high sensitivity and specificity. For example, by designing specific primers, fragments of genes related to H2S synthase genes or antibiotic resistance genes can be amplified, so as to determine whether the bacteria are antibiotic-resistant bacteria associated with H2S. Some new detection techniques such as fluorescent probe method, using fluorescent probes with specific recognition of H2S or antibiotic-resistant bacteria, can realize rapid and sensitive detection of antibiotic-resistant bacteria associated with H2S, and the results can be obtained in a shorter period of time and can be detected in situ, which provides a more convenient means of clinical diagnosis. Gholap S P proposed that H₂S, an emerging metabolic marker associated with β-lactam antibiotics, can serve as a tool to screen for bacterial antibiotic resistance.50 Nanoprobes selectively monitoring changes in H2S concentration for imaging and screening of antibiotic resistance can be used as a specific diagnostic technique for screening β-lactam antibiotic-resistant S. aureus and non-resistant S. aureus, and exploring new diagnostic strategies for the identification of H2S-associated resistance pathways.51 In addition, biosensor technology is gradually being applied to the detection of such bacteria, which allows real-time and rapid detection of bacteria and related markers by combining biometric elements with signal conversion elements.
Although the current research on the application of H2S markers in the diagnosis of bacterial antibiotic is relatively limited, this H2S-based diagnostic method has certain advantages, such as relatively simple detection, and can directly reflect the antibiotic resistance to specific antibiotics. With further research, it is expected to further expand the application of H2S markers in the diagnosis of more types of bacterial antibiotic and improve the accuracy and efficiency of diagnosis.
Potential Applications of H2S in the Treatment of Antibiotic Resistance
Development of H2S Synthase Inhibitors
H2S exhibits potential applications in the treatment of bacterial antibiotic resistance. In particular, the inhibition of H2S production or activity may serve as a therapeutic strategy in instances where endogenous H2S production contributes to antibiotic resistance against antibiotics. This approach involves the development of inhibitors targeting H2S-producing enzymes, thereby compromising the antibiotic resistance mechanisms and enhancing antibiotic efficacy. In 2021, Konstantin Shatalin employed a virtual screening method to identify compounds capable of specifically binding to S. aureus cystathionine-γ-lyase (SaCSE), utilizing the X-ray crystallographic structure of SaCSE as a basis for this identification. Subsequent to this, both in vitro and in vivo assays were conducted to evaluate various functionalities, ultimately leading to the identification of three compounds capable of inhibiting H2S-producing enzymes. These compounds, when combined with antibiotic-enzyme inhibitors, have the potential to reduce treatment failure in acute infections, decrease colonization, prevent conversion to chronicity and relapse, shorten the duration of treatment, and mitigate the risk of antibiotic resistance emergence or spread.45 In contrast, for bacteria that do not naturally produce H2S, such as Acinetobacter baumannii, the external supplementation of H2S can impart resistance to a wide range of antibiotics. This observation indicates a potential novel strategy for managing infections caused by these bacterial strains.52
Clearance of Endogenous H2S to Disrupt Bacterial Biofilm Formation
In contrast to the inhibition of H2S synthase at its source, direct scavenging of H2S has been explored through the development of various materials aimed at reducing H2S levels within bacteria. Wei Zhang, following chemical and structural optimization, designed compound 7b based on nitrobenzofurane scaffolds, which can accurately identify and scavenge H2S. This compound enhances the bactericidal capabilities of macrophages and neutrophils, thereby inhibiting and eradicating bacterial biofilm formation. Furthermore, it significantly amplifies the antimicrobial efficacy of gentamicin in models of P. aeruginosa induced pneumonia and skin wounds.53 Metal-Organic Frameworks, a class of porous materials composed of inorganic metal ions or clusters as central nodes and organic ligands, form a crystalline network through coordination bonds. These materials possess advantageous physicochemical properties, such as high specific surface area, adjustable pore size, high porosity, and excellent biocompatibility, which facilitate efficient drug loading, targeted delivery, and controlled release, making them highly promising for biomedical applications.54
The metal-organic framework zirconium (IV) terephthalate (UiO-66-MA), subsequently loaded with gentamicin to form UiO-66-MA@Gm, serves as a low-toxicity, structurally stable, and high-quality drug delivery carrier. It effectively removes H2S produced by bacteria and enhances the sensitivity of antibiotics. This methodology offers innovative perspectives for the design of novel antibacterial materials. Weizhong Yang developed an “enzyme-mimicking bioheterojunction”, primarily composed of CuFe2S3 and lactate oxidase. CuFe2S3 facilitates the production of potent bactericidal ·OH from H2O2 and depletes antioxidant substances within bacteria, such as glutathione, thereby disrupting bacterial metabolism. Bacterial infections and lactic acid accumulation create a localized acidic environment in wounds, prompting the material to release H2S. As a reducing gas, H2S can reduce metal ions from a high valence state (eg Fe3+, Cu2+) to a low valence state (eg Fe2+, Cu+), thereby continuously generating ROS and accelerating the valence cycle of metal ions. This cycling enables the material to persistently produce ROS, such as ·OH, thereby enhancing its antibacterial efficacy.55
Conclusions and Future Prospects
H2S, produced by bacteria through enzymes like CBS, CSE, and 3MST, functions as a defense mechanism that significantly enhances bacterial antibiotic resistance. Antibiotics induce bacteria to produce ·OH, which kill bacteria through oxidative stress. Endogenously produced H2S in bacteria counteracts this oxidative stress by scavenging ·OH, chelating Fe2+, and enhancing antioxidant enzyme activity. Moreover, H2S can attenuate antibiotic-induced DNA damage in bacteria, facilitating the formation of persister bacterial populations. It also promotes biofilm formation, enhances biofilm stability, and contributes to bacterial colonization.
H2S presents significant potential for advancements in bacterial antibiotic research. In the realm of diagnostics, it is anticipated that assays based on H2S will undergo further optimization and expansion. This includes enhancing current H2S detection technologies to improve their sensitivity and specificity, thereby enabling more accurate diagnosis of bacterial antibiotic resistance. Concurrently, research is being conducted to explore the feasibility of utilizing H2S as a biomarker for a broader range of bacterial antibiotics, with the aim of extending its application in clinical diagnostic settings.50 From a therapeutic perspective, comprehensive research into the optimal combination of H2S and antibiotics, including the determination of the appropriate H2S dosage, timing, and modality of combination, may yield more effective therapeutic outcomes. Furthermore, elucidating the mechanisms by which H2S modulates the expression of bacterial drug-resistance genes could facilitate the development of novel therapeutic strategies centered on H2S regulation, such as reversing bacterial antibiotic resistance through the modulation of H2S-related signaling pathways. Concurrently, exploring the impact of H2S on bacterial biofilms presents a promising avenue for developing innovative approaches to disrupt biofilms and enhance the efficacy of antibiotics against antibiotic-resistant bacteria within these biofilms.
Abbreviations
H2S, hydrogen sulfide; AMR, Antimicrobial Resistance; CSE, cystathionine-γ-lyase; CBS, cystathionine-β-synthase; 3MST, 3-mercaptopyruvate sulfurtransferase; ROS, reactive oxygen species; E. coli, Escherichia coli; B. anthraci, Bacillus anthracis; P. aeruginosa, Pseudomonas aeruginosa; S. aureus, Staphylococcus aureus; SRB, sulphate-reducing bacteria; DSV, Desulfovibrio bacteria; OH, hydroxyl radicals; H2O2, hydrogen peroxide; Fe2+, ferrous iron; ISCs, iron-sulfur clusters; fur, ferric uptake regulator; SaCSE, S. aureus CSE; UiO-66-MA, metal-organic framework zirconium (IV) terephthalate.
Author Contributions
All authors made a significant contribution to the work reported, including conception, drafting, revising or critically reviewing the article; gave final approval of the version to be published; have agreed on the journal to which the article has been submitted; and agree to be accountable for all aspects of the work.
Funding
This work was funded by the First Affiliated Hospital of Dalian Medical University and Dalian Institute of Chemical Physics, Chinese Academy of Sciences (CAS) Medical-Engineering Cooperation Projects (No.DMU-1&DICP UN202207), Dalian Medical Science Research Project in 2023 (No.2023DF003).
Disclosure
The authors declare no conflicts of interest in this work.
References
1. Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47(11):1181–1247.
2. Rudd KE, Johnson SC, Agesa KM, et al. Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study. Lancet. 2020;395(10219):200–211.
3. McCulloch TR, Wells TJ, Souza-Fonseca-Guimaraes F. Towards efficient immunotherapy for bacterial infection. Trend Microbiol. 2022;30(2):158–169.
4. Sommer LM, Johansen HK, Molin S. Antibiotic resistance in Pseudomonas aeruginosa and adaptation to complex dynamic environments. Microbial Genomics. 2020;6(5):e000370.
5. Uddin TM, Chakraborty AJ, Khusro A, et al. Antibiotic resistance in microbes: history, mechanisms, therapeutic strategies and future prospects. J Infect Public Health. 2021;14(12):1750–1766.
6. Zhou H, Huang D, Sun Z, Chen X. Effects of intestinal Desulfovibrio bacteria on host health and its potential regulatory strategies: a review. Microbiol Res. 2024;284:127725.
7. GBD 2021 Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050. Lancet. 2024;404(10459):1199–1226.
8. Laws M, Shaaban A, Rahman KM. Antibiotic resistance breakers: current approaches and future directions. FEMS Microbiol Rev. 2019;43(5):490–516.
9. Wallace JL, Ferraz JG, Muscara MN. Hydrogen sulfide: an endogenous mediator of resolution of inflammation and injury. Antioxid Redox Signaling. 2012;17(1):58–67.
10. Pope K, So YT, Crane J, Bates MN. Ambient geothermal hydrogen sulfide exposure and peripheral neuropathy. Neurotoxicology. 2017;60:10–15.
11. Wang R. Two’s company, three’s a crowd: can H2S be the third endogenous gaseous transmitter? FASEB J. 2002;16(13):1792–1798.
12. Wagner CA. Hydrogen sulfide: a new gaseous signal molecule and blood pressure regulator. J Nephrology. 2009;22(2):173–176.
13. Dilek N, Papapetropoulos A, Toliver-Kinsky T, Szabo C. Hydrogen sulfide: an endogenous regulator of the immune system. Pharmacol Res. 2020;161:105119.
14. Yang G, Wang R. H2S and blood vessels: an overview. Handbook Exp Pharmacol. 2015;230:85–110.
15. Nagpure BV, Brain BJS. Learning, and Memory: role of H2S in Neurodegenerative Diseases. Handbook Exp Pharmacol. 2015;230:193–215.
16. Głowacka U, Brzozowski T, Synergisms MM. Discrepancies and interactions between hydrogen sulfide and carbon monoxide in the gastrointestinal and digestive system physiology, pathophysiology and pharmacology. Biomolecules. 2020;10(3).
17. Chen HJ, Ngowi EE, Qian L, et al. Role of Hydrogen Sulfide in the Endocrine System. Front Endocrinol. 2021;12:704620.
18. Sun X, Mao C, Xie Y, et al. Therapeutic potential of hydrogen sulfide in reproductive system disorders. Biomolecules. 2024;14(5):445.
19. Kamoun P. Endogenous production of hydrogen sulfide in mammals. Amino Acids. 2004;26(3):243–254.
20. Shatalin K, Shatalina E, Mironov A, Nudler E. H2S: a universal defense against antibiotics in bacteria. Science. 2011;334(6058):986–990.
21. Tanaka N, Hatano T, Saito S, et al. Generation of hydrogen sulfide from sulfur assimilation in Escherichia coli. J General Appl Microbiol. 2019;65(5):234–239.
22. Cavallini D, Mondovi B, De Marco C, Scioscia-Santoro A. The mechanism of desulphhydration of cysteine. Enzymologia. 1962;24:253–266.
23. Zhao K, Li H, Li S, Yang G. Regulation of cystathionine gamma-lyase/H2S system and its pathological implication. Front Biosci. 2014;19(8):1355–1369.
24. Rao SP, Dobariya P, Bellamkonda H, More SS. Role of 3-mercaptopyruvate sulfurtransferase (3-MST) in physiology and disease. Antioxidants. 2023;12(3):603.
25. Blachier F, Andriamihaja M, Larraufie P, Ahn E, Lan A, Kim E. Production of hydrogen sulfide by the intestinal microbiota and epithelial cells and consequences for the colonic and rectal mucosa. Am J Physiol Gastrointest Liver Physiol. 2021;320(2):G125–G135.
26. Singh SB, Carroll-Portillo A, Lin HC. Desulfovibrio in the gut: the enemy within? Microorganisms. 2023;11(7):1772.
27. Tran PQ, Bachand SC, Hotvedt JC, et al. Physiological and genomic evidence of cysteine degradation and aerobic hydrogen sulfide production in freshwater bacteria. mSystems. 2023;8(3):e0020123.
28. Imlay JA. The molecular mechanisms and physiological consequences of oxidative stress: lessons from a model bacterium. Nat Rev Microbiol. 2013;11(7):443–454.
29. Oguri T, Schneider B, Reitzer L. Cysteine catabolism and cysteine desulfhydrase (CdsH/STM0458) in Salmonella enterica serovar typhimurium. J Bacteriol. 2012;194(16):4366–4376.
30. Mironov A, Seregina T, Nagornykh M, et al. Mechanism of H(2)S-mediated protection against oxidative stress in Escherichia coli. Proc Natl Acad Sci USA. 2017;114(23):6022–6027.
31. Djaman O, Outten FW, Imlay JA. Repair of oxidized iron-sulfur clusters in Escherichia coli. J Biol Chem. 2004;279(43):44590–44599.
32. Kohanski MA, Dwyer DJ, Hayete B, Lawrence CA, Collins JJ. A common mechanism of cellular death induced by bactericidal antibiotics. Cell. 2007;130(5):797–810.
33. Troxell B, Hassan HM. Transcriptional regulation by Ferric Uptake Regulator (Fur) in pathogenic bacteria. Front Cell Infect Microbiol. 2013;3:59.
34. Porcheron G, Dozois CM. Interplay between iron homeostasis and virulence: fur and RyhB as major regulators of bacterial pathogenicity. Vet Microbiol. 2015;179(1–2):2–14.
35. Wassarman KM, Repoila F, Rosenow C, Storz G, Gottesman S. Identification of novel small RNAs using comparative genomics and microarrays. Genes Dev. 2001;15(13):1637–1651.
36. Ma Y, Yang X, Wang H, et al. CBS-derived H2S facilitates host colonization of Vibrio cholerae by promoting the iron-dependent catalase activity of KatB. PLoS Pathogens. 2021;17(7):e1009763.
37. Chen M, Zhang W, Han L, et al. A CysB regulator positively regulates cysteine synthesis, expression of type III secretion system genes, and pathogenicity in Ralstonia solanacearum. Mol Plant Pathol. 2022;23(5):679–692.
38. Kouzuma A, Endoh T, Omori T, Nojiri H, Yamane H, Habe H. Transcription factors CysB and SfnR constitute the hierarchical regulatory system for the sulfate starvation response in Pseudomonas putida. J Bacteriol. 2008;190(13):4521–4531.
39. He L, He T, Farrar S, Ji L, Liu T, Ma X. Antioxidants maintain cellular redox homeostasis by elimination of reactive oxygen species. Cell Physiol Biochem. 2017;44(2):532–553.
40. Wu G, Gao H. [Endogenous production and physiological functions of hydrogen sulfide in facultative anaerobic bacteria]. Wei Sheng wu Xue Bao. 2017;57(2):170–178.
41. Michel B. After 30 years of study, the bacterial SOS response still surprises us. PLoS Biol. 2005;3(7):e255.
42. Baharoglu Z, Sos MD. the formidable strategy of bacteria against aggressions. FEMS Microbiol Rev. 2014;38(6):1126–1145.
43. Niu H, Gu J, Zhang Y. Bacterial persisters: molecular mechanisms and therapeutic development. Signal Transduct Target Ther. 2024;9(1):174.
44. Fisher RA, Gollan B, Helaine S. Persistent bacterial infections and persister cells. Nat Rev Microbiol. 2017;15(8):453–464.
45. Shatalin K, Nuthanakanti A, Kaushik A, et al. Inhibitors of bacterial H(2)S biogenesis targeting antibiotic resistance and tolerance. Science. 2021;372(6547):1169–1175.
46. Hall CW, Mah TF. Molecular mechanisms of biofilm-based antibiotic resistance and tolerance in pathogenic bacteria. FEMS Microbiol Rev. 2017;41(3):276–301.
47. Pang Z, Raudonis R, Glick BR, Lin TJ, Cheng Z. Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies. Biotechnol Adv. 2019;37(1):177–192.
48. Motta JP, Flannigan KL, Agbor TA, et al. Hydrogen sulfide protects from colitis and restores intestinal microbiota biofilm and mucus production. Inflamm Bowel Dis. 2015;21(5):1006–1017.
49. Nzungize L, Ali MK, Wang X, et al. Mycobacterium tuberculosis metC (Rv3340) derived hydrogen sulphide conferring bacteria stress survival. J Drug Targeting. 2019;27(9):1004–1016.
50. Gholap SP, Yao C, Green O, et al. Chemiluminescence detection of hydrogen sulfide release by β-lactamase-catalyzed β-lactam biodegradation: unprecedented pathway for monitoring β-lactam antibiotic bacterial resistance. Bioconjugate Chem. 2021;32(5):991–1000.
51. Gong D, Huang X, Yi Z, et al. Ratiometric fluorescent nanoprobe for imaging and screening of hydrogen sulfide related bacterial resistance. Mater Today Commun. 2022;32:103959.
52. Ng SY, Ong KX, Surendran ST, et al. Hydrogen sulfide sensitizes acinetobacter baumannii to Killing by Antibiotics. Front Microbiol. 2020;11:1875.
53. Sun J, Wang X, Gao Y, et al. H(2)S scavenger as a broad-spectrum strategy to deplete bacteria-derived H(2)S for antibacterial sensitization. Nat Commun. 2024;15(1):9422.
54. Yang J, Yang YW. Metal-organic frameworks for biomedical applications. Small. 2020;16(10):e1906846.
55. He M, Wang Z, Xiang D, et al. A H2S-evolving alternately-catalytic enzyme bio-heterojunction with antibacterial and macrophage-reprogramming activity for all-stage infectious wound regeneration. Adv Mater. 2024;36(35):e2405659.
© 2025 The Author(s). This work is published and licensed by Dove Medical Press Limited. The
full terms of this license are available at https://www.dovepress.com/terms
and incorporate the Creative Commons Attribution
- Non Commercial (unported, 4.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted
without any further permission from Dove Medical Press Limited, provided the work is properly
attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.
